MoneyWorks4Me

Brooks Laboratories - Quaterly Results

13 Aug 2025 Evaluate
The sales for the June 2025 quarter moved up 42.26% to Rs. 255.12 millions as compared to Rs. 179.33 millions during the corresponding quarter last year.The Total Profit for the quarter ended June 2025 of Rs. 26.50 millions grew from Rs.-2.12 millionsThe company reported a good operating profit of 33.43 millions compared to 3.50 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 255.12 179.33 42.26 255.12 179.33 42.26 825.57 794.86 3.86
Other Income 2.17 0.69 214.49 2.17 0.69 214.49 8.83 9.18 -3.81
PBIDT 33.43 3.50 855.14 33.43 3.50 855.14 58.58 41.73 40.38
Interest 3.01 1.62 85.80 3.01 1.62 85.80 10.28 8.45 21.66
PBDT 30.42 1.88 1518.09 30.42 1.88 1518.09 48.30 33.28 45.13
Depreciation 3.92 4.00 -2.00 3.92 4.00 -2.00 16.02 17.73 -9.64
PBT 26.50 -2.12 -1350.00 26.50 -2.12 -1350.00 32.28 15.55 107.59
TAX 0.00 0.00 0.00 0.00 0.00 0.00 1.75 0.26 573.08
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 26.50 -2.12 -1350.00 26.50 -2.12 -1350.00 30.53 15.29 99.67
Equity 294.57 262.47 12.23 294.57 262.47 12.23 294.57 262.47 12.23
PBIDTM(%) 13.10 1.95 571.39 13.10 1.95 571.39 7.10 5.25 35.16
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..